RE:RE:if vxl is even just a part of the solution, it is a long process, it will take many months for whoever might come up with the successful vaccine, just because a company is doing phase 1 trial doesnt mean its vaccine is effective and will reach the finish line. There is also a posibility that multiple vaccines can induce immunity and there could be many vaccines that will be available, which is good because there are 7.5 billion people worldwide and not a single company can produce billions of the needed shots. As long as a company can generate very good results in the tests along the way, it will be positive for the company and the science that those companies are doing, and therefore it will validate their reputation, knowledge, patents and its intrinsic value
bligicka wrote: The only way this play will pay off is if Big Pharma buys Vaxil out .....but since Human trials are already under way Vaxil might want to focus on it's cancer drugs instead of dropping tons on money on covid when it's looking like the competition has already beat them to the punch
bigbanktheory wrote: that could be good too, i don't know if just one company or entity can solve this alone, but if they can, all the power to them. the two reasons i hang on is because one, they were on the who list, if there were so many companies on that list, there could be some sort of connection there, and second, i would really like to see how the patents work out???? just a guess, do your dd, and glta